Workflow
Banco Santander(SAN)
icon
Search documents
Banco Santander (Brasil) S.A.: NOTICE TO THE MARKET
Prnewswire· 2025-02-28 22:00
Group 1 - Banco Santander (Brasil) S.A. filed its Annual Report on Form 20-F for the year 2024 with the U.S. SEC and the Brazilian CVM on February 28, 2025 [1] - The 20-F report includes certifications under the U.S. Sarbanes-Oxley Act, confirming the effectiveness of Santander Brasil's internal controls and procedures [2] - Independent auditors PricewaterhouseCoopers Auditores Independentes Ltda. provided an audit opinion on the financial statements and internal controls as of December 31, 2024 [2] Group 2 - Shareholders of Santander Brasil can request a hard copy of the 20-F document, which includes complete audited financial statements, free of charge [3]
Banco Santander: Starting To Get Its Due From The Market
Seeking Alpha· 2025-02-22 10:22
Core Viewpoint - Banco Santander (NYSE: SAN) has shown strong performance with a ~26% total return for its American Depositary Shares (ADSs) since the last update in October, driven by robust fourth quarter results and optimistic guidance for FY2025 [1] Group 1 - The fourth quarter results of Banco Santander were robust, contributing to the strong performance of its shares [1] - The company provided bullish guidance for FY2025, indicating positive future expectations [1]
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
GlobeNewswire· 2025-02-22 07:30
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE UCCD study support overall efficacy and safety of duvakitug in all pre-specified subgroups across the different doses New endpoints presented include findings on clinical and endoscopic outcomes and histological-endoscopic mucosal improvementFindings to form the basis for a phase 3 program, anticipated to start in H2 2025 Paris and Parsippany, NJ, February 22, 2025. S ...
Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
GlobeNewswire· 2025-02-13 19:09
Group 1 - Sanofi has filed its 2024 U.S. Form 20-F and French "Document d'Enregistrement Universel" containing the Annual Financial Report [1] - These documents are accessible on Sanofi's website and the websites of the SEC and AMF [1] - A hard copy of the financial statements can be requested free of charge [1] Group 2 - Sanofi is an innovative global healthcare company focused on improving lives through scientific advancements [2] - The company operates in approximately 100 countries and aims to transform medical practices [2] - Sanofi provides life-changing treatments and vaccines while prioritizing sustainability and social responsibility [2]
Banco Santander Credits Technology Platforms for Achievement of Record Results
PYMNTS.com· 2025-02-05 20:06
Core Insights - Banco Santander achieved record results in 2024, driven by its technology platforms [1][2] - The bank reported record levels in net interest income, net fee income, total income, and profit [2] - The bank added 8 million new customers, bringing its total to 173 million across 10 core markets [3] Technology and Strategy - Santander's scale allows it to build its own technology platforms, enhancing customer service while reducing costs [2] - The launch of Openbank in the U.S. and partnerships with Amazon and Apple reflect the bank's strategy to improve customer solutions and transform its operating model [3][4] - Zinia, Santander's consumer finance platform, partnered with Amazon to launch a new Amazon Visa card in Germany [4] Future Outlook - Santander aims to have a full-service digital bank in the U.S. by the end of 2025 [4] - The bank's global platforms are enhancing its wealth business and payments connectivity [5] - The Executive Chair expressed confidence in the bank's potential for increased profitability in 2025, citing a new era of value creation [5]
Banco Santander(SAN) - 2024 Q4 - Earnings Call Transcript
2025-02-05 16:52
Financial Data and Key Metrics Changes - The company achieved a record profit of €12.6 billion, supported by strong revenue growth and an increase of 8 million customers [9][11] - Revenue growth was reported at 10% in constant euros, with fee income up 11% [12][10] - The return on tangible equity (RoTE) increased to 16.3%, and the capital ratio reached an all-time high of 12.8% [10][11][26] Business Line Data and Key Metrics Changes - Retail and Consumer businesses showed double-digit growth, contributing significantly to net interest income (NII) [41][50] - Corporate and Investment Banking (CIB) revenues grew by 14%, while Wealth revenues increased by 15% [41][24] - Payments volume rose by 11%, with a target EBITDA margin close to 30% for 2025 [25][26] Market Data and Key Metrics Changes - The U.S. market is expected to be a major contributor to earnings growth in 2025, with corporate banking fees increasing by 21% [24][100] - The company noted that higher interest rates benefit the retail franchise in Europe, while other markets may perform better with lower rates [16][41] Company Strategy and Development Direction - The company is focused on becoming the best open financial services platform, leveraging its global scale and local leadership [29][30] - The ONE Transformation initiative aims to simplify operations and improve efficiency, with expectations of continued cost reductions and revenue growth [10][46] - The company plans to distribute €10 billion in share buybacks to shareholders for 2025 and 2026, reflecting strong capital generation [64][66] Management's Comments on Operating Environment and Future Outlook - Management anticipates a challenging macro environment in 2025, including lower euro rates and potential volatility [61][62] - The outlook for 2025 includes stable revenue expectations around €62 billion, with a focus on reducing costs in absolute terms [62][63] - The company remains confident in achieving or exceeding its financial targets set in 2023 [59][60] Other Important Information - The cost-to-income ratio improved to 41.8%, the best in 15 years, with expectations for further improvements [48][49] - The non-performing loan (NPL) ratio improved to 3.05%, reflecting stable credit quality across the footprint [50][51] Q&A Session Summary Question: Trade-offs between organic and inorganic growth - Management prioritizes profitable organic growth, followed by ordinary dividends and share buybacks, with inorganic growth being complementary to strategic aims [71][75] Question: Cost-to-income improvement potential - The ONE Transformation initiative has significant upside potential, especially in retail and consumer areas, which represent 70% of costs [77][78] Question: UK market sustainability - The UK retail business is expected to perform well, with asset quality remaining resilient and improvements from the ONE Transformation [94][96] Question: U.S. market contribution to earnings growth - The U.S. is expected to be a significant contributor to earnings growth, with a focus on consumer banking and corporate investment banking [100][102] Question: Capital distribution and CET1 target - The CET1 target for 2025 is set at 13%, with excess capital being returned to shareholders through buybacks and dividends [113][117]
Banco Santander(SAN) - 2024 Q4 - Earnings Call Presentation
2025-02-05 12:30
5 February 2025 FY'24 Important information Non-IFRS and alternative performance measures This presentation contains financial information prepared according to International Financial Reporting Standards (IFRS) and taken from our consolidated financial statements, as well as alternative performance measures (APMs) as defined in the Guidelines on Alternative Performance Measures issued by the European Securities and Markets Authority (ESMA) on 5 October 2015, and other non-IFRS measures. The APMs and non-IF ...
Santander shares jump 7% after lender announces record quarterly profit, 10-billion-euro buyback
CNBC· 2025-02-05 09:42
Shares of Banco Santander jumped after Spain's largest lender reported record profit in the fourth quarter and announced plans for 10 billion euros ($10.4 billion) in share buybacks from 2025 and 2026 earnings and anticipated excess capital.The bank's net profit picked up by 11% year-on-year to 3.265 billion euros in the fourth quarter and by an annual 14% to 12.574 billion euros across the full-year stretch, as Santander noted a pick-up in customer activity, robust margin management and growth across opera ...
Santander's US Digital Bank Platform Marks $2 Billion in Deposits
PYMNTS.com· 2025-02-03 20:09
Santander’s American digital banking platform has surpassed $2 billion in deposits four months after launch.“This achievement represents a significant milestone in the Santander US business strategy to efficiently boost national deposit acquisition that will fuel its leading auto lending franchise and transform its retail bank,” the Spanish lender said in a Monday (Feb. 3) news release.The bank introduced Openbank in October of last year. While the service launched by offering high-yield savings accounts, S ...
Press Release: Sanofi announces buy back of shares from L’Oréal
GlobeNewswire· 2025-02-03 06:30
Core Viewpoint - Sanofi has announced the acquisition of 2.3% of its shares from L'Oréal as part of its share buyback program, emphasizing its commitment to sustainable value creation for shareholders [1][2]. Group 1: Transaction Details - The acquisition involves 29,556,650 shares at a price of €101.50 per share, totaling €3 billion, which reflects a 2.8% discount to the closing price on January 31, 2025 [2]. - The shares acquired from L'Oréal will be cancelled by April 29, 2025, and the transaction is expected to be accretive to Sanofi's earnings per share [2][3]. - After the cancellation, L'Oréal will own 7.2% of Sanofi, with 13.1% of voting rights [3]. Group 2: Governance and Compliance - The acquisition is structured as an off-market block trade and complies with French Commercial Code regulations, having been approved by Sanofi's Board of Directors [2][4]. - An independent expert, Finexsi, confirmed that the price of the repurchased shares is fair and that the transaction will not adversely affect Sanofi's financial balances [4]. Group 3: Strategic Importance - François Roger, CFO of Sanofi, highlighted the long-standing partnership with L'Oréal and the importance of this transaction in maintaining strategic priorities while enhancing shareholder value [2]. - The transaction underscores Sanofi's focus on sustainable value creation and the preservation of key partnerships [2].